Inhibiting a Protein Reduces Alzheimer's Plaques and Inflammation in Mice
Author Information
Author(s): Fontán-Baselga Teresa, Cañeque-Rufo Héctor, Rivera-Illades Elisa, Gramage Esther, Zapico José María, de Pascual-Teresa Beatriz, Ramos-Álvarez María Del Pilar, Herradón Gonzalo, Vicente-Rodríguez Marta
Primary Institution: Universidad San Pablo-CEU
Hypothesis
Does inhibiting receptor protein tyrosine phosphatase β/ζ reduce Aβ plaques and neuroinflammation in Alzheimer's disease models?
Conclusion
Inhibiting RPTPβ/ζ with MY10 significantly reduced Aβ plaques and neuroinflammation in the hippocampus of APP/PS1 mice.
Supporting Evidence
- Treatment with 90 mg/kg MY10 significantly reduced the number and size of Aβ plaques.
- MY10 treatment decreased the interaction of glial cells with Aβ plaques.
- MY10 treatment reduced pro-inflammatory markers in the hippocampus.
Takeaway
Researchers found that a drug can help clean up harmful proteins in the brains of mice with Alzheimer's, which might help them feel better.
Methodology
APP/PS1 mice were treated with MY10, an RPTPβ/ζ inhibitor, for 14 days, and various brain analyses were conducted.
Limitations
The study does not clarify whether the reduction in Aβ deposition reflects a lasting effect or a delay in progression.
Participant Demographics
Eight-to ten-month-old APP/PS1 double-transgenic mice.
Statistical Information
P-Value
p = 0.0214
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website